Calumet (CLMT) EBITDA (2023 - 2026)

Calumet (CLMT) has 4 years of EBITDA data on file, last reported at -$171.3 million in Q1 2026.

• Quarterly EBITDA fell 251.75% year-over-year to -$171.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$13.9 million (up 81.92% YoY) and the FY2025 annual result came in at $108.7 million, up 1241.98% from the prior year.
• EBITDA declined to -$171.3 million in Q1 2026 per CLMT's latest filing, from -$64.5 million in the prior quarter.
• Across five years, EBITDA topped out at $322.9 million in Q3 2025 and bottomed at -$171.3 million in Q1 2026.
• The 4-year median for EBITDA is -$14.4 million (2023), against an average of $10.8 million.
• Peak annual rise in EBITDA reached 665.5% in 2025, while the deepest fall reached 1729.03% in 2025.
• Tracing CLMT's EBITDA over 4 years: stood at -$13.9 million in 2023, then surged by 263.31% to $22.7 million in 2024, then plunged by 384.14% to -$64.5 million in 2025, then sank by 165.58% to -$171.3 million in 2026.
• Per Business Quant, the three latest CLMT EBITDA figures stand at -$171.3 million (Q1 2026), -$64.5 million (Q4 2025), and $322.9 million (Q3 2025).

Peer Comparison